Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia

    Access Status
    Fulltext not available
    Authors
    Butler, K.
    Day, C.
    Dietze, P.
    Bruno, R.
    Alati, Rosa
    Burns, L.
    Date
    2015
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Butler, K. and Day, C. and Dietze, P. and Bruno, R. and Alati, R. and Burns, L. 2015. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia. Journal of Substance Abuse Treatment. 58: pp. 90-94.
    Source Title
    Journal of Substance Abuse Treatment
    DOI
    10.1016/j.jsat.2015.06.008
    ISSN
    0740-5472
    School
    School of Public Health
    URI
    http://hdl.handle.net/20.500.11937/72323
    Collection
    • Curtin Research Publications
    Abstract

    © 2015 Elsevier Inc.. Background: Recent efforts in Australia to engage people who inject drugs (PWID) in hepatitis C (HCV) care have focussed on opioid substitution treatment (OST) services as a delivery site. This approach potentially excludes non-opioid using PWID. This study aimed to determine differences between those currently receiving OST and those not among a sample of PWID. Methods: Additional questions on HCV testing were included in the 2013 Illicit Drug Reporting System (IDRS), an annual sentinel surveillance system. The IDRS recruits PWID in all Australian capital cities from a range of sources, predominantly needle and syringe programs. All participants are reimbursed AUD$40 for a ~. 45. minute interview-administered survey. Results: Current OST was reported by 44% of the total sample, and two-thirds reported an opioid as their drug of choice. Those participants who reported current OST were significantly more likely than those not in OST to report heroin as their drug of choice (65% vs. 43%, p < 0.0.001) and the drug injected most often (53% vs. 30%, p < 0.001). Compared to those in OST, those not in OST were more likely to report methamphetamine as their drug of choice (29% vs. 14%, p < 0.001) or drug injected most often (33% vs. 17%, p < 0.001). Current OST clients were more likely to have been tested for HCV antibodies (anti-HCV) than those not in OST (96% vs. 93%, p < 0.05) and to report an anti-HCV positive result (75% vs. 64%, p < 0.001). Those receiving OST were no more likely than those not to undergo further HCV-related testing (e.g. RNA) (62% vs. 56%, p=. 0.136). Both groups reported further HCV-related testing was undertaken primarily at a community general practice. Discussion: Despite a large proportion of current PWID receiving OST, there remains a substantial minority who are neither seeking nor eligible for treatment. Efforts to improve access to HCV care for PWID in Australia therefore need to be expanded beyond OST, especially given the large proportion of participants who reported inadequate HCV testing.

    Related items

    Showing items related by title, author, creator and subject.

    • Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies
      Betts, K.; Chan, G.; McIlwraith, F.; Dietze, P.; Whittaker, E.; Burns, L.; Alati, Rosa (2016)
      © 2016 Society for the Study of Addiction Aims: To test if polysubstance use profiles and drug-related outcomes differ between those receiving and not receiving opioid substitution therapies (OST) among people who inject ...
    • Impact of HIV status notification on risk behaviors among men who inject drugs in Kermanshah, west of Iran
      Noroozi, A.; Mirzazadeh, A.; Farhoudian, A.; Hajebi, A.; Khankeh, H.; Higgs, Peter; Sharifi, H.; Armoon, B.; Noroozi, M. (2016)
      Background: It is unclear whether knowing of current HIV status is associated with change in injecting behaviors among people who inject drugs (PWID) in Iran. The objective of the present study was to determine whether ...
    • Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia?
      Nielsen, S.; Bruno, R.; Lintzeris, N.; Fischer, J.; Carruthers, Susan; Stoove, M. (2011)
      Introduction and Aims. Non-prescribed use of pharmaceutical opioid analgesics (POA) has been escalating internationally. In Australia, few studies have examined if POA users have similar characteristics and treatment needs ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.